The GM-CSF receptor utilizes Β-catenin and Tcf4 to specify macrophage lineage differentiation

Differentiation

Volumn 83, Issue 1, 2012, Pages 47-59

  Brown, Anna L ^a,b   Salerno, Diana G ^a   Sadras, Teresa ^a,b   Engler, Grant A ^a   Kok, Chung H ^a,b   Wilkinson, Christopher R ^b,c   Samaraweera, Saumya E ^b   Sadlon, Timothy J ^c   Perugini, Michelle ^a,b   Lewis, Ian D ^a,d   Gonda, Thomas J ^e   D'Andrea, Richard J ^a,b,d,f  

^a CENTRE FOR CANCER BIOLOGY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c Women's and Children's Health Research Institute   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Catenin; Myeloid; Signal transduction; Tcf4; Transcription factor

Indexed keywords

BETA CATENIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; TYROSINE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE TARGETING; GRANULOCYTE; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TCF4 GENE; TRANSCRIPTION REGULATION; UPREGULATION; WNT GENE;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BETA CATENIN; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL PROLIFERATION; CYTOKINE RECEPTOR COMMON BETA SUBUNIT; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; GRANULOCYTES; MACROPHAGES; MICE; MUTATION; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

EID: 80053471768     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2011.08.003     Document Type: Article

References (54)

1. Aoki M., Sobek V., Maslyar D.J., Hecht A., Vogt P.K. Oncogenic transformation by beta-catenin: deletion analysis and characterization of selected target genes. Oncogene 2002, 21:6983-6991.
2. Bikkavilli R.K., Feigin M.E., Malbon C.C. p38 mitogen-activated protein kinase regulates canonical Wnt-beta-catenin signaling by inactivation of GSK3beta. Journal of Cell Science 2008, 121:3598-3607.
3. Brown A.L., Peters M., D'Andrea R.J., Gonda T.J. Constitutive mutants of the GM-CSF receptor reveal multiple pathways leading to myeloid cell survival, proliferation, and granulocyte-macrophage differentiation. Blood 2004, 103:507-516.
4. Brown A.L., Wilkinson C.R., Waterman S.R., Kok C.H., Salerno D.G., Diakiw S.M., Reynolds B., Scott H.S., Tsykin A., Glonek G.F., Goodall G.J., Solomon P.J., Gonda T.J., D'Andrea R.J. Genetic regulators of myelopoiesis and leukemic signaling identified by gene profiling and linear modeling. Journal of Leukocyte Biology 2006, 80:433-447.
5. Conti L., Gessani S. GM-CSF in the generation of dendritic cells from human blood monocyte precursors: recent advances. Immunobiology 2008, 213:859-870.
6. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789.
7. D'Andrea R.J., Harrison-Findik D., Butcher C.M., Finnie J., Blumbergs P., Bartley P., McCormack M., Jones K., Rowland R., Gonda T.J., Vadas M.A. Dysregulated hematopoiesis and a progressive neurological disorder induced by expression of an activated form of the human common beta chain in transgenic mice. Journal of Clinical Investigation 1998, 102:1951-1960.
8. Dijkers P.F., van Dijk T.B., de Groot R.P., Raaijmakers J.A., Lammers J.W., Koenderman L., Coffer P.J. Regulation and function of protein kinase B and MAP kinase activation by the IL-5/GM-CSF/IL-3 receptor. Oncogene 1999, 18:3334-3342.
9. Dranoff G., Crawford A.D., Sadelain M., Ream B., Rashid A., Bronson R.T., Dickersin G.R., Bachurski C.J., Mark E.L., Whitsett J.A. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994, 264:713-716.
10. Enzler T., Gillessen S., Manis J.P., Ferguson D., Fleming J., Alt F.W., Mihm M., Dranoff G. Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. Journal of Experimental Medicine 2003, 197:1213-1219.
11. Ernst A., Aigner M., Nakata S., Engel F., Schlotter M., Kloor M., Brand K., Schmitt S., Steinert G., Rahbari N., Koch M., Radlwimmer B., Weitz J., Lichter P. A gene signature distinguishing CD133hi from CD133-colorectal cancer cells: essential role for EGR1 and downstream factors. Pathology (Phila) 2011, 43:220-227.
12. Gery S., Gombart A.F., Yi W.S., Koeffler C., Hofmann W.K., Koeffler H.P. Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia. Blood 2005, 106:2827-2836.
13. Grinnell K.L., Casserly B., Harrington E.O. Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium. American Journal of Physiology-Lung Cellular and Molecular Physiology 2010, 298:L361-L370.
14. Gu H., Maeda H., Moon J.J., Lord J.D., Yoakim M., Nelson B.H., Neel B.G. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. Molecular and Cellular Biology 2000, 20:7109-7120.
15. Guthridge M.A., Powell J.A., Barry E.F., Stomski F.C., McClure B.J., Ramshaw H., Felquer F.A., Dottore M., Thomas D.T., To B., Begley C.G., Lopez A.F. Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch. The EMBO Journal 2006, 25:479-489.
16. Hamilton J.A. Colony-stimulating factors in inflammation and autoimmunity. Nature Reviews Immunology 2008, 8:533-544.
17. Hansen G., Hercus T.R., McClure B.J., Stomski F.C., Dottore M., Powell J., Ramshaw H., Woodcock J.M., Xu Y., Guthridge M., McKinstry W.J., Lopez A.F., Parker M.W. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell 2008, 134:496-507.
18. Hatzis P., van der Flier L.G., van Driel M.A., Guryev V., Nielsen F., Denissov S., Nijman I.J., Koster J., Santo E.E., Welboren W., Versteeg R., Cuppen E., van de Wetering M., Clevers H., Stunnenberg H.G. Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Molecular and Cellular Biology 2008, 28:2732-2744.
19. Holmes T., O'Brien T.A., Knight R., Lindeman R., Shen S., Song E., Symonds G., Dolnikov A. Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth. Stem Cells 2008, 26:1288-1297.
20. Holmes T., O'Brien T.A., Knight R., Lindeman R., Symonds G., Dolnikov A. The role of glycogen synthase kinase-3beta in normal haematopoiesis, angiogenesis and leukaemia. Current Medicinal Chemistry 2008, 15:1493-1499.
21. Huang J., Zhang Y., Bersenev A., O'Brien W.T., Tong W., Emerson S.G., Klein P.S. Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice. Journal of Clinical Investigation 2009, 119:3519-3529.
22. Jenkins B.J., Blake T.J., Gonda T.J. Saturation mutagenesis of the beta subunit of the human granulocyte-macrophage colony-stimulating factor receptor shows clustering of constitutive mutations, activation of ERK MAP kinase and STAT pathways, and differential beta subunit tyrosine phosphorylation. Blood 1998, 92:1989-2002.
23. Jenkins B.J., D'Andrea R., Gonda T.J. Activating point mutations in the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors suggest the involvement of beta subunit dimerization and cell type-specific molecules in signalling. The EMBO Journal 1995, 14:4276-4287.
24. Kajiguchi T., Chung E.J., Lee S., Stine A., Kiyoi H., Naoe T., Levis M.J., Neckers L., Trepel J.B. FLT3 regulates beta-catenin tyrosine phosphorylation, nuclear localization, and transcriptional activity in acute myeloid leukemia cells. Leukemia 2007, 21:2476-2484.
25. Kondo M., Scherer D.C., Miyamoto T., King A.G., Akashi K., Sugamura K., Weissman I.L. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature 2000, 407:383-386.
26. Laslo P., Spooner C.J., Warmflash A., Lancki D.W., Lee H.J., Sciammas R., Gantner B.N., Dinner A.R., Singh H. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 2006, 126:755-766.
27. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., Zhang Z., Lin X., He X. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002, 108:837-847.
28. Lopez A.F., Hercus T.R., Ekert P., Littler D.R., Guthridge M., Thomas D., Ramshaw H.S., Stomski F., Perugini M., D'Andrea R., Grimbaldeston M., Parker M.W. Molecular basis of cytokine receptor activation. IUBMB Life 2010, 62:509-518.
29. Martinez-Moczygemba M., Doan M.L., Elidemir O., Fan L.L., Cheung S.W., Lei J.T., Moore J.P., Tavana G., Lewis L.R., Zhu Y., Muzny D.M., Gibbs R.A., Huston D.P. Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1. Journal of Experimental Medicine 2008, 205:2711-2716.
30. McClure B.J., Hercus T.R., Cambareri B.A., Woodcock J.M., Bagley C.J., Howlett G.J., Lopez A.F. Molecular assembly of the ternary granulocyte-macrophage colony- stimulating factor receptor complex. Blood 2003, 101:1308-1315.
31. McClure B.J., Woodcock J.M., Harrison-Findik D., Lopez A.F., D'Andrea R.J. GM-CSF binding to its receptor induces oligomerisation of the common beta-subunit. Cytokine 2001, 13:240-243.
32. McCormack M.P., Gonda T.J. Myeloproliferative disorder and leukaemia induced in mice by different classes of constitutive mutants of the human IL-3/IL-5/GM-CSF receptor common beta subunit. Oncogene 1999, 18:7190-7199.
33. McCormack M.P., Gonda T.J. Novel murine myeloid cell lines which exhibit a differentiation switch in response to IL-3 or GM-CSF, or to different constitutively active mutants of the GM-CSF receptor beta subunit. Blood 2000, 95:120-127.
34. Metcalf D., Begley C.G., Williamson D.J., Nice E.C., De Lamarter J., Mermod J.J., Thatcher D., Schmidt A. Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Experimental Hematology 1987, 15:1-10.
35. Min I.M., Pietramaggiori G., Kim F.S., Passegue E., Stevenson K.E., Wagers A.J. The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells. Cell Stem Cell 2008, 2:380-391.
36. Miyajima A., Mui A.L., Ogorochi T., Sakamaki K. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 1993, 82:1960-1974.
37. Nishinakamura R., Nakayama N., Hirabayashi Y., Inoue T., Aud D., McNeil T., Azuma S., Yoshida S., Toyoda Y., Arai K., et al. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. Immunity 1995, 2:211-222.
38. Okuda K., Smith L., Griffin J.D., Foster R. Signaling functions of the tyrosine residues in the beta chain of the granulocyte-macrophage colony-stimulating factor receptor. Blood 1997, 90:4759-4766.
39. Otero K., Turnbull I.R., Poliani P.L., Vermi W., Cerutti E., Aoshi T., Tassi I., Takai T., Stanley S.L., Miller M., Shaw A.S., Colonna M. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin. Nature Immunology 2009, 10:734-743.
40. Paine R., Preston A.M., Wilcoxen S., Jin H., Siu B.B., Morris S.B., Reed J.A., Ross G., Whitsett J.A., Beck J.M. Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. Journal of Immunology 2000, 164:2602-2609.
41. Perugini M., Brown A.L., Salerno D.G., Booker G.W., Stojkoski C., Hercus T.R., Lopez A.F., Hibbs M.L., Gonda T.J., D'Andrea R.J. Alternative modes of GM-CSF receptor activation revealed using activated mutants of the common beta-subunit. Blood 2010, 115:3346-3353.
42. Perugini M., Kok C.H., Brown A.L., Wilkinson C.R., Salerno D.G., Young S.M., Diakiw S.M., Lewis I.D., Gonda T.J., D'Andrea R.J. Repression of Gadd45alpha by activated FLT3 and GM-CSF receptor mutants contributes to growth, survival and blocked differentiation. Leukemia 2009, 23:729-738.
43. Powell J.A., Thomas D., Barry E.F., Kok C.H., McClure B.J., Tsykin A., To L.B., Brown A., Lewis I.D., Herbert K., Goodall G.J., Speed T.P., Asou N., Jacob B., Osato M., Haylock D.N., Nilsson S.K., D'Andrea R.J., Lopez A.F., Guthridge M.A. Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML. Blood 2009, 114:4859-4870.
44. Ramshaw H.S., Guthridge M.A., Stomski F.C., Barry E.F., Ooms L., Mitchell C.A., Begley C.G., Lopez A.F. The Shc-binding site of the betac subunit of the GM-CSF/IL-3/IL-5 receptors is a negative regulator of hematopoiesis. Blood 2007, 110:3582-3590.
45. Rottbauer W., Saurin A.J., Lickert H., Shen X., Burns C.G., Wo Z.G., Kemler R., Kingston R., Wu C., Fishman M. Reptin and pontin antagonistically regulate heart growth in zebrafish embryos. Cell 2002, 111:661-672.
46. Saegusa M., Hashimura M., Kuwata T., Hamano M., Watanabe J., Kawaguchi M., Okayasu I. Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells. The Journal of Pathology 2008, 216:521-532.
47. Scheller M., Huelsken J., Rosenbauer F., Taketo M.M., Birchmeier W., Tenen D.G., Leutz A. Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. Nature Immunology 2006, 7:1037-1047.
48. Smith A., Metcalf D., Nicola N.A. Cytoplasmic domains of the common á-chain of the GM-CSF/IL-3/IL-5 receptors that are required for inducing differentiation or clonal suppression in myeloid leukaemic cell lines. The EMBO Journal 1997, 16:451-464.
49. Suzuki T., Sakagami T., Rubin B.K., Nogee L.M., Wood R.E., Zimmerman S.L., Smolarek T., Dishop M.K., Wert S.E., Whitsett J.A., Grabowski G., Carey B.C., Stevens C., van der Loo J.C., Trapnell B.C. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. Journal of Experimental Medicine 2008, 205:2703-2710.
50. Thornton T.M., Pedraza-Alva G., Deng B., Wood C.D., Aronshtam A., Clements J.L., Sabio G., Davis R.J., Matthews D.E., Doble B., Rincon M. Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science 2008, 320:667-670.
51. van de W.M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., van der H.K., Batlle E., Coudreuse D., Haramis A.P., Tjon-Pon-Fong M., Moerer P., van den B.M., Soete G., Pals S., Eilers M., Medema R., Clevers H. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002, 111:241-250.
52. Yochum G.S., McWeeney S., Rajaraman V., Cleland R., Peters S., Goodman R.H. Serial analysis of chromatin occupancy identifies beta-catenin target genes in colorectal carcinoma cells. Proceedings of National Academy of Science USA 2007, 104:3324-3329.
53. Zhang L., Friedman A.D. SHP2 tyrosine phosphatase stimulates CEBPA gene expression to mediate cytokine-dependent granulopoiesis. Blood 2011.
54. Zhao C., Blum J., Chen A., Kwon H.Y., Jung S.H., Cook J.M., Lagoo A., Reya T. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 2007, 12:528-541.